Singapore - English - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - alglucosidase alfa - injection, powder, lyophilized, for solution - 52.5 mg - alglucosidase alfa 50 mg/vial

Israel - English - Ministry of Health

sanofi israel ltd - alglucosidase alfa - powder for concentrate for infusion - alglucosidase alfa 50 mg/vial - alglucosidase alfa - alglucosidase alfa - myozyme is indicated for long-term enzyme replacement therapy (ert) in patients with a confirmed diagnosis of pompe disease (acid alpha-glucosidase deficiency). the benefits of myozyme in patients with late-onset pompe disease have not been established.

Ireland - English - HPRA (Health Products Regulatory Authority)

s.a.l.f. s.p.a. laboratorio farmacologico - labetalol hydrochloride - solution for injection/infusion - 5 milligram(s)/millilitre - labetalol

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

genzyme europe b.v., netherlands - alglucosidase alfa - powder for concentrate for solution for infusion - 5 mg/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

genzyme europe b.v., netherlands - alglucosidase alfa - powder for concentrate for solution for infusion - 5 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - mesna - solution for inj/inf - 100 mg/ml - mesna

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

genzyme therapeutics ltd - imiglucerase - powder for solution for infusion - 400unit

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - alglucosidase alfa 52.5mg;  ;  ;   - powder for infusion concentrate - 50 mg/10ml - active: alglucosidase alfa 52.5mg       excipient: dibasic sodium phosphate heptahydrate mannitol monobasic sodium phosphate monohydrate nitrogen polysorbate 80 - myozyme is indicated for the long - term treatment of patients with a confirmed diagnosis of pompe disease (acid alfa - glucosidase deficiency).

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: sanofi-aventis philippines, inc.; distributor: sanofi-aventis philippines, inc. - alglucosidase alfa - powder for concentrate for solutions for infusion (iv) - 50 mg

Canada - English - Health Canada

sanofi genzyme, a division of sanofi-aventis canada inc - alglucosidase alfa - powder for solution - 50mg - alglucosidase alfa 50mg - enzymes